Stock HLUN B H. LUNDBECK A/S
Add to a list
To use this feature you must be a member
Log inSign up

Consensus H. Lundbeck A/S

Equities

HLUN B

DK0061804770

Market Closed - Nasdaq Copenhagen
Other stock markets
 11:20:00 2024-07-08 am EDT 		5-day change 1st Jan Change
39.96 DKK +1.27% Intraday chart for H. Lundbeck A/S +3.52% +21.98%
Jun. 26 Otsuka and Lundbeck's PTSD Treatment Moves Forward as FDA Accepts New Drug Application MT
Jun. 25 US FDA Accepts Lundbeck, Otsuka's New Drug Application for PTSD Combo Treatment MT

Evolution of the average Target Price on H. Lundbeck A/S

Price target over the last 5 years

History of analyst recommendation changes

dd.YRLIqH4b9eEGc7GiFF-qr1l8n5TMChrBDQsbyjF8dB8.OWeR6k4shbFrAYPGXBrMyC5K3e6OOVKqTn5MiFY5EFIZfKmYNSO-mFQU-A~754aa0e735840e799d761df08f5eff81

Analyst Recommendations on H. Lundbeck A/S

H LUNDBECK : Q1 beat adds momentum to the recent share price rally Alphavalue
H LUNDBECK : Lundbeck is well-poised to sail through the transition period Alphavalue
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
39.96 DKK
Average target price
39.96 DKK
Spread / Average Target
-0.00%
High Price Target
51 DKK
Spread / Highest target
+27.63%
Low Price Target
35 DKK
Spread / Lowest Target
-12.41%

Consensus detail

Consensus revision (last 18 months)

Analysts covering H. Lundbeck A/S

alphavalue Abhishek Raval

Ratings for H. Lundbeck A/S

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. HLUN B Stock
  4. Consensus H. Lundbeck A/S